Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies.

Authors:
Laux I; Jain A; Singh S; Agus DB.

Journal:
Br J Cancer

Publication Year: 2006

DOI:
10.1038/sj.bjc.6602875

PMCID:
PMC2361091

PMID:
16306877

View on PubMed View on PMC View Publisher
Journal Information

Journal Title: Br J Cancer

Detailed journal information not available.

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"This study was supported by a Prostate Cancer Foundation Young Investigator Award to IL, an AACR-California Department of Health Services Career Development Award in Prostate Cancer Research to AJ (97-12013) and a Prostate Cancer Foundation grant and NIH Prostate SPORE P50 CA92131 to DBA. Sharat Singh is the Chief Technical Officer in Oncology at Monogram Biosciences, Inc., and David B Agus is a member on its Scientific Advisory Board."

Evidence found in paper:

"This study was supported by a Prostate Cancer Foundation Young Investigator Award to IL, an AACR-California Department of Health Services Career Development Award in Prostate Cancer Research to AJ (97-12013) and a Prostate Cancer Foundation grant and NIH Prostate SPORE P50 CA92131 to DBA. Sharat Singh is the Chief Technical Officer in Oncology at Monogram Biosciences, Inc., and David B Agus is a member on its Scientific Advisory Board."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025